Showing results (461-470 of 478) with videos related to

Sort By:
Pageof 48
Frontiers in Pharmacology|March 9, 2026
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH studyHemavathi Baskarane, Mohit Kumar Divakar, Akhil P Santhosh, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2023
Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational ProfileSurabhi Jain, Ansh Goswami, Moien R Lone, et al.
Cancer Communications (London, England)|July 6, 2022
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyAjaz A Bhat, Sabah Nisar, Mayank Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.
South Asian Journal of Cancer|March 10, 2025
Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is MorePrasad Narayanan, Shyam Aggarwal, Manish Singhal, et al.
The Indian Journal of Medical Research|November 9, 2022
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from IndiaAkash Kumar, Saphalta Baghmar, Prashant Mehta, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
South Asian Journal of Cancer|March 24, 2025
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)Purvish M Parikh, Ghanashyam Biswas, Nilesh Ashok Dhamne, et al.
Circulation|March 28, 2026
Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and MenHarmony R Reynolds, Akiko Maehara, Bobby Heydari, et al.
Pageof 48